Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.56117 | 58 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.31737 | 54 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.33333 | 54 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.22636 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.29267 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.40972 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.36534 | 53 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.54259 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.27758 | 53 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.31197 | 54 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.3315 | 54 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.28031 | 53 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.32293 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.32096 | 54 |